Vaccination has pushed the percentage of residents in Geneva with antibodies against the SARS-CoV-2 virus up to 67%, according to a recent study by Geneva’s HUG hospital. © Kukotaekaterina | Dreamstime.com To some extent, Geneva has been at the forefront of Switzerland’s experience with Covid-19. Since the beginning of the pandemic, the canton has recorded Switzerland’s highest rate of infection, 54% above the Swiss average. Geneva has also been a leader on vaccination. By 11 July 2021, with 102 doses administered per 100 residents, Geneva trailed only the canton of Basel-City (105) on vaccination roll out. The Swiss average was 95 doses per 100 people. Geneva’s high rates of infection and vaccination appear to have combined to deliver a high rate SARS-CoV-2
Topics:
Investec considers the following as important: 3) Swiss Markets and News, 3a) Health, Coronavirus Switzerland, Covid-19 Switzerland, Editor's Choice, Featured, health, newsletter
This could be interesting, too:
Jane L. Johnson writes Contrived Scarcity and Antitrust Lawsuits—“It’s Not a Bag, It’s a Birkin”
David Gordon writes What Is Consent?
Lance Roberts writes Trump Presidency – Quick Thoughts On Market Impact
Robert P. Murphy writes How Can Mining Asteroids in the Future Make Us Richer Today?
Vaccination has pushed the percentage of residents in Geneva with antibodies against the SARS-CoV-2 virus up to 67%, according to a recent study by Geneva’s HUG hospital.
To some extent, Geneva has been at the forefront of Switzerland’s experience with Covid-19. Since the beginning of the pandemic, the canton has recorded Switzerland’s highest rate of infection, 54% above the Swiss average.
Geneva has also been a leader on vaccination. By 11 July 2021, with 102 doses administered per 100 residents, Geneva trailed only the canton of Basel-City (105) on vaccination roll out. The Swiss average was 95 doses per 100 people.
Geneva’s high rates of infection and vaccination appear to have combined to deliver a high rate SARS-CoV-2 antibodies (67%) in the population.
Given Geneva’s high rate of infection and lead on vaccinations, it is likely that the level of SARS-CoV-2 antibodies in other Swiss cantons is lower than Geneva’s 67%.
Reflecting the age-based priority of the vaccination rollout, among the sample of 3,121 Geneva residents tested, 95% of those aged over 75 and 85% of those aged 50 to 65 had antibodies. Further down the age spectrum the percentages fell to 60% of those aged 18 to 50, 40% of those aged 12 to 15, 35% of those aged 6 to 12 and 25% of those under 6 years old.
It is highly likely that the virus will continue to circulate among the young and a vaccination programme aimed at this group to cut transmission would make sense, according to an expert at the hospital.
Tags: Coronavirus Switzerland,Covid-19 Switzerland,Editor's Choice,Featured,Health,newsletter